In a 25-year-old man with adult-onset type II citrullinemia, liver transplantation resulted in elimination of hyperammonemia and amino acid abnormalities associated with the disease. Postoperatively, a high intensity area in the right cingulate gyrus on a T2-weighted brain magnetic resonance imaging (MRI) also disappeared, suggesting that it reflected an early reversible lesion due to the hyperammonemia. Moreover, the serum level of pancreatic secretory trypsin inhibitor (PSTI), which had been elevated, was normalized. Since the levels of PSTI mRNAand PSTI have been reported to be increased in the livers of type II citrullinemia patients, measurement of serum PSTI levels could aid in the diagnosis of this disease. (Internal Medicine 36: 408-412, 1997) 
Introduction
Citrullinemia is an autosomal recessive disease caused by deficiency ofargininosuccinate synthetase (ASS; E.C. 6.3.4.5). Saheki et al analyzed the enzyme abnormalities in Japanese citrullinemia patients and classified them into three types (types I, II and III) (1) . The classic neonatal and/or infantile form was assigned to type I (abnormal kinetics of the enzyme) and type III (undetectable or extremely low levels of the enzyme). The enzyme defects in types I and III are found in all tissues and/or cells where ASSis expressed. Type II citrullinemia is caused by a decreased level of ASS with normal kinetic properties in the liver but normal ASSlevels in other tissues, such as the kidney and brain, and fibroblasts (1) (2) (3) (4) . Type II is clinically characterized by a sudden onset of consciousness disturbance, a high serum citrulline concentration, a slightly increased serum arginine concentration, and hyperammonemia.Most Japanese patients with adult-onset citrullinemia are affected by type II citrullinemia. Although no effective treatments for type II citrullinemia have been available, orthotopic liver transplantation was recently performed on two Japanese patients and proved to be effective in elimination of hyperammonemia and plasma amino acid abnormalities (5, 6; Kawamoto et al., manuscript in preparation). Wereport here a 25-year-old man with adult-onset type II citrullinemia whoalso underwent liver transplantation. The treatment resulted in elimination of the metabolic abnormalities associated with citrullinemia. Moreover, it resulted in normalization of an abnormal intensity area in the right cingulate gymson a brain magnetic resonance imaging (MRI) and of the serum levels of some tumor markers, the association of neither of which with this disease has been previously reported.
Case Report
A 25-year-old man was the second child of healthy secondcousin parents. His elder brother died of pneumonia at age 9; his sister has rigid spine syndrome which requires nocturnal ventilatory support (7) . The patient had scarlet fever at age 3 and a propensity for cheese since childhood. He was healthy and workedfor a companyuntil finger tremor and several episodes of temporary spatial disorientation, restlessness, and sleeplessness occurred 4 months before admission. On April 4, 1995, he was admitted to the Tokyo Metropolitan Neurological Hospital. Physical examination revealed that the patient was of short stature (162.7 cm, 58.5 kg) and was suffering from hepatomegaly (palpable 4 cm below the costal margin). Neurologically, he was alert and intelligent but sometimes showed temporal and spatial disorientation. Prominent positional and flapping tremor of the four limbs was present.
Otherwise he was neurologically normal. The activities of the 5 urea cycle enzymes in the liver were measured by the methods ofSchimke et al (26) Complete blood cell count (CBC), erythrocyte sedimentation rate, and serum Creactive protein (CRP) level were normal. Autoantibodies were not detected in the serum except for antinuclear antibody (at x80 serum dilution, homogeneous pattern). Although serum carcinoembryonic antigen (CEA) and alphafetoprotein levels were normal, serum levels of the following so-called tumor markers were elevated: pancreatic secretory trypsin inhibitor (PSTI) 123.2 ng/ml (normal: 5.9-22.7), ferritin 436.6 ng/ml (normal: 10-250), immunosuppressive acidic protein (IAP) 731 jag/ml (normal: less than 550), and carbohydrate antigen 19-9 (CA 19-9) 52.0U/ml (normal: less than 37). Plasma, urine, and cerebrospinal fluid (CSF) amino acid determinations revealed increased citrulline levels (Table 1) . Arginine and glutamine levels were slightly increased in the plasma, and the glutamine and ammonialevels were increased in the CSF. Due to the amino acid abnormalities observed we diagnosed citrullinemia. Subsequent measurement of the urea cycle enzyme activities in a liver biopsy specimen showed a selective decrease of ASS activity and confirmed the diagnosis ( Table 2 ).
The biopsy specimen showed severe fatty change on light microscopy ( Fig. 1A) . Mild fibrosis occurred in the portal areas and it extended to the central veins. However,there were no regenerative nodules. These findings have previously been associated with type II citrullinemia (8, 9). Conventional electron microscopic examinations showed no specific changes of cell organella including mitochondria. A computed tomography (CT) scan (Fig. IB) revealed an enlarged liver as a diffuse low-density area, whichwas compatible with the microscopic findings. A T2-weighted brain MRI revealed a localized highintensity area in the right cingulate gyrus ( Fig. 2A) .
Electroencephalography (EEG) showed diffuse slowing with 9
waves and an occasional triphasic wave. ( 10) . We have continued postoperative follow-up of the patient for one year. Soonafter surgery, the fluctuating consciousness disturbance and flapping tremor completely disappeared, accompaniedby normalization of the abnormal EEGfindings.
The high-intensity area in the cingulate gyms on the T2-weighted MRI disappeared by September 1995 (Fig. 2B) . The blood ammonia level normalized (1 18.7 nmol/ml, Table 1 ) and serum levels of the tumor markers except for CA19-9 also normalized (PSTI 16.5 ng/ml, ferritin 18.8 ng/ml, IAP 474 jug/ ml, CA19-9 59.5 U/ml) within 2.5 months after the surgery.
The plasma and urine citrulline levels gradually decreased and were in the physiological range one year after the surgery (Table 1) . He returned to his previous employment 10 months postoperatively. 
Adult-Onset Type II Citrullinemia
Analysis of the patient's parents' and sister's plasma amino acid levels revealed normal profiles, but his sister showed transient hyperammonemiaafter physical exercise.
Discussion
The diagnosis of adult-onset type II citrullinemia was confirmed by the sudden onset of consciousness disturbance in adulthood, hyperammonemia, abnormal amino acid profiles, severe fatty liver, and selective deficiency of ASS activity in the liver. Anautosomal recessive modeof inheritance was suspected because of the parents' consanguinity. The consciousness disturbance, flapping tremor, and characteristic EEGfindings probably reflected the metabolic encephalopathy due to the hyperammonemia and partly due to the imbalance of amino acid levels in the body fluids. Regarding brain CTfindings related to such metabolic encephalopathy, previous reports mentioned brain edemaoccurring chiefly in the early stage of the disease (6, 1 1-13), and brain atrophy in patients who had arelatively long clinical course (6, 14, 15) . In the present patient, the localized lesion in the cingulate gyms on the brain MRIdisappeared after the surgery, suggesting that it reflected an early reversible disease process which would have extended to other brain regions if left untreated. Based on an experimental model of hyperammonemic coma in primates, it is inferred that the swelling ofastrocytes is the primary response to hyperammonemia (16, 17) . Astrocytes are considered to be the sites of incorporation of ammonium into glutamine, resulting in an increase in their endogenous osmolarity and swelling (17) . In addition, a strong relationship between hyperammonemia,neurologic dysfunction, and a high cerebrospinal fluid glutamine concentration has been detected in hepatic encephalopathy (18) . Therefore, the high CSF ammonia and glutamine levels in this patient and previously reported cases of adult-onset type II citrullinemia (9, 19) might indicate disruption of the compensative astrocyte function for hyperammonemia. EEG, brain magnetic resonance imaging and measurement of CSF glutamine and ammonia levels may be helpful in detection of early brain dysfunction in this disease. Another remarkable finding in the present case was the high concentrations of so-called tumor markers in the serum. Among these markers, PSTI showed the most prominent serum concentration increase. Concerning the molecular basis of adult-onset type II citrullinemia, causative abnormalities within the ASS gene remain to be identified (20) . Recently, however, Kobayashi et al reported detecting overexpression of PSTI mRNAand a high concentration ofPSTI in the liver of9 type II citrullinemia patients tested (21) . In specimens of the livers of these patients, no malignant histological changes were observed. Although PSTI is knownto be an acute phase reactant, the expression level of CRPmRNA, which is another major acute phase reactant, was not increased in the liver of these patients. Although the levels of PSTI mRNA,PSTI and CRP mRNAin our patient's liver were not measured, the serum levels ofPSTI and CRPwere completely consistent with their expression patterns in the livers of Kobayashi et al's type II citrullinemia patients (21) . In addition, the fact that the serum PSTI level normalized after the liver transplantation suggests that the excess serum PSTI originated from the liver. It also indicates that the putative factors which regulate the expression of PSTI and most likely ASS in the liver are present in the liver itself and not in extrahepatic tissues or other organs. Furthermore, our results suggest a possible relationship between PSTI and the primary defect of adult-onset type II citrullinemia. In addition to serum PSTI, the other markers such as serum ferritin and serum IAP could be useful for diagnosing citrullinemia.
Regarding therapy for adult-onset type II citrullinemia, patients have been treated for hyperammonemiawith such therapies as a low protein diet, hypertonic glucose transfusion, dietary arginine supplementation, sodium citrate or sodium benzoate administration, lactulose administration, nonabsorbed antibiotic administration, peritoneal dialysis, and plasmapheresis. Transfusion of branched chain amino acids has also been performed but a subsequent decrease in consciousness level and exacerbation of hyperammonemia were noted in one patient ( 12) . These conservative therapies result in temporary alleviation of hyperammonemia and/or consciousness disturbance.
However, the long-term prognosis is poor, with comaand a status epilepticus occurring, followed by death due to brain swelling usually within two years of onset of encephalopathy (1 1 , 12, 19, 22, 23) . Ifthepatient survives longerthan two years, severe organic brain damage is inevitable (14, 15) . Recently two Japanese patients were treated with orthotopic liver transplantation (5, 6; Kawamoto et al, manuscript in preparation). In these patients, hyperammonemiaand abnormalities in plasma aminoacids were alleviated to an extent not achieved by the above conservative treatments. In addition, the patients are not only alive at 7.5 and 2 years, respectively, after the surgery, but also live normal lives. The present condition of the present patient also indicates that liver transplantation is an effective therapy for correction of the metabolic abnormalities associated with citrullinemia. Furthermore, it suggests that liver transplantation in the early stage of the disease could prevent development in the brain of organic lesions due to the metabolic abnormalities.
Since the original metabolic disturbance of adult-onset type II citrullinemia is localized in the liver, development of the disease seems to be a good indication for liver transplantation. Moreover, the transplant should be performed as soon as possible after onset of the disease before irreversible brain damageoccurs.
